Toho Holdings Co., Ltd.
Toho Holdings Co., Ltd. (8129.T) Stock Competitors & Peer Comparison
See (8129.T) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 8129.T | ¥4,170.00 | +0.17% | 268.4B | 15.89 | ¥261.05 | +3.98% |
| 4502.T | ¥5,137.00 | +1.52% | 8.1T | 42.94 | ¥119.43 | +3.90% |
| 4507.T | ¥3,013.00 | +0.69% | 2.6T | 15.09 | ¥200.80 | +2.34% |
| 4523.T | ¥3,947.00 | -0.83% | 1.1T | 29.57 | ¥136.72 | +3.96% |
| 4581.T | ¥8,580.00 | -0.12% | 703.3B | 83.43 | ¥102.84 | N/A |
| 4506.T | ¥1,496.50 | -3.11% | 682.5B | 5.66 | ¥268.98 | N/A |
| 4530.T | ¥6,040.00 | +0.00% | 425.2B | 22.47 | ¥268.78 | +1.99% |
| 4540.T | ¥3,740.00 | -0.37% | 286.8B | 10.22 | ¥376.33 | +3.82% |
| 4516.T | ¥4,070.00 | -1.19% | 279.7B | 9.41 | ¥440.89 | +2.99% |
| 4887.T | ¥1,731.00 | -2.34% | 204.8B | 17.80 | ¥99.62 | +3.10% |
Stock Comparison
8129.T vs 4502.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4502.T has a market cap of 8.1T. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4502.T trades at ¥5,137.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4502.T's P/E ratio is 42.94. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4502.T's ROE of +0.03%. Regarding short-term risk, 8129.T is more volatile compared to 4502.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 4502.T's competition here
8129.T vs 4507.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4507.T has a market cap of 2.6T. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4507.T trades at ¥3,013.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4507.T's P/E ratio is 15.09. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4507.T's ROE of +0.14%. Regarding short-term risk, 8129.T is less volatile compared to 4507.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4507.T's competition here
8129.T vs 4523.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4523.T has a market cap of 1.1T. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4523.T trades at ¥3,947.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4523.T's P/E ratio is 29.57. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4523.T's ROE of +0.04%. Regarding short-term risk, 8129.T is less volatile compared to 4523.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4523.T's competition here
8129.T vs 4581.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4581.T has a market cap of 703.3B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4581.T trades at ¥8,580.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4581.T's P/E ratio is 83.43. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4581.T's ROE of +0.02%. Regarding short-term risk, 8129.T is more volatile compared to 4581.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 4581.T's competition here
8129.T vs 4506.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4506.T has a market cap of 682.5B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4506.T trades at ¥1,496.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4506.T's P/E ratio is 5.66. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4506.T's ROE of +0.42%. Regarding short-term risk, 8129.T is less volatile compared to 4506.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4506.T's competition here
8129.T vs 4530.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4530.T has a market cap of 425.2B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4530.T trades at ¥6,040.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4530.T's P/E ratio is 22.47. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4530.T's ROE of +0.07%. Regarding short-term risk, 8129.T is more volatile compared to 4530.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 4530.T's competition here
8129.T vs 4540.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4540.T has a market cap of 286.8B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4540.T trades at ¥3,740.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4540.T's P/E ratio is 10.22. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4540.T's ROE of +0.09%. Regarding short-term risk, 8129.T is less volatile compared to 4540.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4540.T's competition here
8129.T vs 4516.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4516.T has a market cap of 279.7B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4516.T trades at ¥4,070.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4516.T's P/E ratio is 9.41. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4516.T's ROE of +0.11%. Regarding short-term risk, 8129.T is less volatile compared to 4516.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4516.T's competition here
8129.T vs 4887.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4887.T has a market cap of 204.8B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4887.T trades at ¥1,731.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4887.T's P/E ratio is 17.80. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4887.T's ROE of +0.06%. Regarding short-term risk, 8129.T is less volatile compared to 4887.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4887.T's competition here
8129.T vs 4553.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4553.T has a market cap of 192.7B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4553.T trades at ¥3,825.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4553.T's P/E ratio is 36.73. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4553.T's ROE of +0.03%. Regarding short-term risk, 8129.T is less volatile compared to 4553.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4553.T's competition here
8129.T vs 4551.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4551.T has a market cap of 178.5B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4551.T trades at ¥6,350.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4551.T's P/E ratio is 33.00. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4551.T's ROE of +0.03%. Regarding short-term risk, 8129.T is more volatile compared to 4551.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 4551.T's competition here
8129.T vs 4547.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4547.T has a market cap of 166.2B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4547.T trades at ¥3,905.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4547.T's P/E ratio is 12.09. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4547.T's ROE of +0.06%. Regarding short-term risk, 8129.T is less volatile compared to 4547.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4547.T's competition here
8129.T vs 4521.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4521.T has a market cap of 153.9B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4521.T trades at ¥4,010.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4521.T's P/E ratio is 284.27. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4521.T's ROE of +0.01%. Regarding short-term risk, 8129.T is less volatile compared to 4521.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4521.T's competition here
8129.T vs 4534.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4534.T has a market cap of 123.2B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4534.T trades at ¥3,410.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4534.T's P/E ratio is 15.58. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4534.T's ROE of +0.06%. Regarding short-term risk, 8129.T is less volatile compared to 4534.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4534.T's competition here
8129.T vs 4559.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4559.T has a market cap of 102.2B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4559.T trades at ¥2,280.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4559.T's P/E ratio is 12.09. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4559.T's ROE of +0.09%. Regarding short-term risk, 8129.T is less volatile compared to 4559.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4559.T's competition here
8129.T vs 4886.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4886.T has a market cap of 84.5B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4886.T trades at ¥2,880.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4886.T's P/E ratio is 15.58. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4886.T's ROE of +0.08%. Regarding short-term risk, 8129.T is less volatile compared to 4886.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4886.T's competition here
8129.T vs 4569.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4569.T has a market cap of 73.9B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4569.T trades at ¥1,272.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4569.T's P/E ratio is 7.93. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4569.T's ROE of +0.02%. Regarding short-term risk, 8129.T is less volatile compared to 4569.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4569.T's competition here
8129.T vs 4554.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4554.T has a market cap of 58.7B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4554.T trades at ¥2,285.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4554.T's P/E ratio is 22.72. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4554.T's ROE of +0.05%. Regarding short-term risk, 8129.T is less volatile compared to 4554.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4554.T's competition here
8129.T vs 4577.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4577.T has a market cap of 35.6B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4577.T trades at ¥1,200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4577.T's P/E ratio is 16.38. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4577.T's ROE of +0.06%. Regarding short-term risk, 8129.T is more volatile compared to 4577.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 4577.T's competition here
8129.T vs 9273.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 9273.T has a market cap of 34.2B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 9273.T trades at ¥799.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 9273.T's P/E ratio is 9.29. In terms of profitability, 8129.T's ROE is +0.07%, compared to 9273.T's ROE of +0.13%. Regarding short-term risk, 8129.T is more volatile compared to 9273.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 9273.T's competition here
8129.T vs 4595.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4595.T has a market cap of 33.1B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4595.T trades at ¥1,734.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4595.T's P/E ratio is 9.66. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4595.T's ROE of +0.18%. Regarding short-term risk, 8129.T is more volatile compared to 4595.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 4595.T's competition here
8129.T vs 2929.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 2929.T has a market cap of 19.2B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 2929.T trades at ¥642.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 2929.T's P/E ratio is -11.33. In terms of profitability, 8129.T's ROE is +0.07%, compared to 2929.T's ROE of -0.16%. Regarding short-term risk, 8129.T is less volatile compared to 2929.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 2929.T's competition here
8129.T vs 4538.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4538.T has a market cap of 17.5B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4538.T trades at ¥2,033.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4538.T's P/E ratio is -4.38. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4538.T's ROE of +0.06%. Regarding short-term risk, 8129.T is more volatile compared to 4538.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 4538.T's competition here
8129.T vs 4574.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4574.T has a market cap of 13B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4574.T trades at ¥256.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4574.T's P/E ratio is 14.09. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4574.T's ROE of +0.07%. Regarding short-term risk, 8129.T is more volatile compared to 4574.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 4574.T's competition here
8129.T vs 4512.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4512.T has a market cap of 9.9B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4512.T trades at ¥280.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4512.T's P/E ratio is 137.20. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4512.T's ROE of +0.02%. Regarding short-term risk, 8129.T is less volatile compared to 4512.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4512.T's competition here
8129.T vs 4524.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4524.T has a market cap of 8.9B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4524.T trades at ¥2,161.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4524.T's P/E ratio is 14.07. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4524.T's ROE of +0.05%. Regarding short-term risk, 8129.T is more volatile compared to 4524.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 4524.T's competition here
8129.T vs 4597.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4597.T has a market cap of 6.8B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4597.T trades at ¥25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4597.T's P/E ratio is -6.78. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4597.T's ROE of -0.55%. Regarding short-term risk, 8129.T is less volatile compared to 4597.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4597.T's competition here
8129.T vs 7079.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 7079.T has a market cap of 6.2B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 7079.T trades at ¥2,570.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 7079.T's P/E ratio is 9.06. In terms of profitability, 8129.T's ROE is +0.07%, compared to 7079.T's ROE of +0.15%. Regarding short-term risk, 8129.T is more volatile compared to 7079.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 7079.T's competition here
8129.T vs 4539.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4539.T has a market cap of 6B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4539.T trades at ¥1,630.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4539.T's P/E ratio is 30.01. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4539.T's ROE of +0.01%. Regarding short-term risk, 8129.T is more volatile compared to 4539.T. This indicates potentially higher risk in terms of short-term price fluctuations for 8129.T.Check 4539.T's competition here
8129.T vs 4883.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4883.T has a market cap of 5.2B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4883.T trades at ¥43.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4883.T's P/E ratio is -1.94. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4883.T's ROE of -0.64%. Regarding short-term risk, 8129.T is less volatile compared to 4883.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4883.T's competition here
8129.T vs 4892.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4892.T has a market cap of 5.1B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4892.T trades at ¥580.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4892.T's P/E ratio is -7.02. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4892.T's ROE of -0.31%. Regarding short-term risk, 8129.T is less volatile compared to 4892.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4892.T's competition here
8129.T vs 4582.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4582.T has a market cap of 4.3B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4582.T trades at ¥79.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4582.T's P/E ratio is -0.76. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4582.T's ROE of -4.24%. Regarding short-term risk, 8129.T is less volatile compared to 4582.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4582.T's competition here
8129.T vs 4586.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4586.T has a market cap of 3.9B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4586.T trades at ¥65.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4586.T's P/E ratio is -3.78. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4586.T's ROE of -0.38%. Regarding short-term risk, 8129.T is less volatile compared to 4586.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4586.T's competition here
8129.T vs 4541.T Comparison May 2026
8129.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8129.T stands at 268.4B. In comparison, 4541.T has a market cap of 2.5B. Regarding current trading prices, 8129.T is priced at ¥4,170.00, while 4541.T trades at ¥35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8129.T currently has a P/E ratio of 15.89, whereas 4541.T's P/E ratio is -0.00. In terms of profitability, 8129.T's ROE is +0.07%, compared to 4541.T's ROE of +0.13%. Regarding short-term risk, 8129.T is less volatile compared to 4541.T. This indicates potentially lower risk in terms of short-term price fluctuations for 8129.T.Check 4541.T's competition here